Skip to content

Implementation research to understand the best approach to implement the Anemia Mukt Bharat prograamm.

Developing & Implementing effective intervention delivery strategies of the Anemia Mukt Bharat program 2.0 to reduce prevalence of anemia amongst vulnerable populations in selected districts of India-An Implementation research study (PRAKASH) Precision Driven Response for Anemia Control and Sustainable Health - PRAKASH

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087746
Enrollment
1350
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Indian Council for Medical Research (ICMR)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 6 to 59 months, (male and female) Children 5-9 years (male and female) Adolescents girls (10 to 19 years) Women of reproductive age (WRA) (20-49 years) Pregnant women Lactating women

Exclusion criteria

Exclusion criteria: High-risk pregnancy or complications (e.g., pre-eclampsia, severe hypertension) requiring specialized care beyond the study protocol. - Diagnosed with chronic or genetic conditions affecting iron levels (e.g., sickle cell disease, thalassemia). - Severe malnutrition (e.g., BMI below 16), as this may require specialized nutritional support. - Current use of iron or anemia treatment not prescribed by the study protocol. - Known gastrointestinal or malabsorption disorders impacting iron absorption (e.g., inflammatory bowel disease). - Recent participation in a similar anemia intervention or iron supplementation study within the past six months

Design outcomes

Primary

MeasureTime frame
Prevalence of anemia (Children 6-23 months less than 10.5 g/dL; Children 24-59 months less than 11 g/dL; Adolescent girls (10-11 years) less than 11.5 g/dL; Adolescent girls (12-19 years) and WRA less than 12 g/dL; Pregnant women (1st & 3rd Trimester less than 11 g/dL; 2nd Trimester less than 10.5 g/dL).Timepoint: 18, 30 and 36 months

Secondary

MeasureTime frame
Prevalence of moderate anemia (Children 6-23 mths: 7.0-9.4 g/dL; Children 24-59 mths: 7.0-9.9 g/dL; Adolescent girls (10-19 yrs) and WRA: 8.0-10.9 g/dL; Pregnant women (1st& 3rd Trimester: 7.0-9.9 g/dL; 2nd Trimester: 7.0-9.4 g/dL) 1.2.2 Prevalence of severe anemia (Children 6-59 mths less than 7 g/dL; Adolescent Girls (10-19 yrs) and WRA less than 8 g/dL; Pregnant women (all trimesters) less than 7g/dL) Timepoint: Prevalence of moderate anemia (Children 6-23 mths: 7.0-9.4 g/dL; Children 24-59 mths: 7.0-9.9 g/dL; Adolescent girls (10-19 yrs) and WRA: 8.0-10.9 g/dL; Pregnant women (1st& 3rd Trimester: 7.0-9.9 g/dL; 2nd Trimester: 7.0-9.4 g/dL) 1.2.2 Prevalence of severe anemia (Children 6-59 mths less than 7 g/dL; Adolescent Girls (10-19 yrs) and WRA less than 8 g/dL; Pregnant women (all trimesters) less than 7g/dL)

Countries

India

Contacts

Public ContactDr Prashanth Thankachan

St Johns Research Institute

prashanth.t@sjri.res.in9886006166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026